5 Jul 2019
AFT signs new deal but maintains profit guidance
Drug company AFT Pharmaceuticals has signed a licensing deal potentially worth more than 10 million US dollars although it's held back lifting its profit forecast.
Recent stories from Business News
Get the RNZ app
for easy access to all your favourite programmes
